Open Access. Powered by Scholars. Published by Universities.®
Biological Phenomena, Cell Phenomena, and Immunity Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (21)
- Cell and Developmental Biology (18)
- Medical Immunology (18)
- Medical Specialties (18)
- Microbiology (16)
-
- Virology (16)
- Genetics and Genomics (15)
- Infectious Disease (15)
- Medical Pathology (15)
- Medical Biochemistry (3)
- Medical Cell Biology (3)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Biochemistry, Biophysics, and Structural Biology (2)
- Diseases (2)
- Genetic Phenomena (2)
- Genetic Processes (2)
- Investigative Techniques (2)
- Medical Genetics (2)
- Medical Molecular Biology (2)
- Medical Neurobiology (2)
- Neurosciences (2)
- Oncology (2)
- Allergy and Immunology (1)
- Amino Acids, Peptides, and Proteins (1)
- Anatomy (1)
- Biochemistry (1)
- Cell Biology (1)
- Institution
-
- University of Nebraska - Lincoln (15)
- Marshall University (2)
- The Texas Medical Center Library (2)
- University of Nebraska Medical Center (2)
- Advocate Health - Midwest (1)
-
- LSU New Orleans (1)
- Liberty University (1)
- Seton Hall University (1)
- Syracuse University (1)
- Thomas Jefferson University (1)
- Touro College and University System (1)
- University of Montana (1)
- University of South Carolina (1)
- Wayne State University (1)
- Zucker School of Medicine at Hofstra/Northwell (1)
- Keyword
-
- <p>Septicemia -- Treatment -- Research.</p> (1)
- <p>Spermiogenesis in animals -- Research.</p> <p>Male infertility -- Research.</p> <p>Male contraception -- Research.</p> (1)
- Aggregate (1)
- Androgen (1)
- Animals (1)
-
- Antigen presentation (1)
- Antiviral defense (1)
- Asbestos (1)
- Atypia (1)
- Autoimmunity (1)
- B-cell lymphoma (1)
- Bioengineering (1)
- Biomarker expression (1)
- Biomedical Science (1)
- Breast Neoplasms/enzymology/genetics/pathology; Cell Line (1)
- Breast cancer (1)
- CD4 T lymphocytes (1)
- CD8 T lymphocytes (1)
- Cannabinoid (1)
- Carmovirus (1)
- Cell Line (1)
- Cell Line, Tumor (1)
- Cell differentiation (1)
- Cerium oxide nanoparticles (1)
- Cervical cancer; EGFR; Hippo; HPV; YAP (1)
- Class 2/genetics/*metabolism; Substrate Specificity; src-Family Kinases/*metabolism (1)
- Combination antiretroviral drugs; Nanoparticles; HIV-1 treatment; Humanized mice model; Tenofovir alafenamide; Elvitegravir; Emtricitabine (1)
- Conditional Knockout (1)
- Correlation matrix (1)
- CpG (1)
- Publication
-
- Nebraska Center for Virology: Faculty Publications (15)
- Dissertations and Theses (Open Access) (2)
- Theses & Dissertations (2)
- Theses, Dissertations and Capstones (2)
- Department of Cancer Biology Faculty Papers (1)
-
- Honors College Theses (1)
- Journal Articles (1)
- Journal of Patient-Centered Research and Reviews (1)
- LSU New Orleans Theses and Dissertations (1)
- Renée Crown University Honors Thesis Projects - All (1)
- Senior Honors Theses (1)
- Seton Hall University Dissertations and Theses (ETDs) (1)
- The Science Journal of the Lander College of Arts and Sciences (1)
- Theses and Dissertations (1)
- Undergraduate Theses, Professional Papers, and Capstone Artifacts (1)
- Publication Type
Articles 31 - 32 of 32
Full-Text Articles in Biological Phenomena, Cell Phenomena, and Immunity
Single-Dose Cpg Immunization Protects Against A Heterosubtypic Challenge And Generates Antigen-Specific Memory T Cells, Alexander J. Vogel, Deborah M. Brown
Single-Dose Cpg Immunization Protects Against A Heterosubtypic Challenge And Generates Antigen-Specific Memory T Cells, Alexander J. Vogel, Deborah M. Brown
Nebraska Center for Virology: Faculty Publications
Despite extensive research, influenza A virus (IAV) remains a major cause of morbidity, mortality, and healthcare expenditure. Emerging pandemics from highly pathogenic IAV strains, such as H5N1 and pandemic H1N1, highlight the need for universal, crossprotective vaccines. Current vaccine formulations generate strain-specific neutralizing antibodies primarily against the outer coat proteins, hemagglutinin and neuraminidase. In contrast to these highly mutable proteins, internal proteins of IAV are more conserved and are a favorable target for developing vaccines that induce strong T cell responses in addition to humoral immunity. Here, we found that intranasal administration with a single dose of CpG and inactivated …
Long-Acting Parenteral Combination Antiretroviral Loaded Nano-Drug Delivery System To Treat Chronic Hiv-1 Infection: A Humanized Mouse Model Study, Subhra Mandal, Guobin Kang, Pavan Kumar Prathipati, Wenjin Fan, Qingsheng Li, Christopher J. Destache
Long-Acting Parenteral Combination Antiretroviral Loaded Nano-Drug Delivery System To Treat Chronic Hiv-1 Infection: A Humanized Mouse Model Study, Subhra Mandal, Guobin Kang, Pavan Kumar Prathipati, Wenjin Fan, Qingsheng Li, Christopher J. Destache
Nebraska Center for Virology: Faculty Publications
Human immunodeficiency virus (HIV) patients are often diagnosed in the chronic stage of HIV/AIDS. Combination antiretroviral therapy (cART) has improved quality of life for HIV-infected patients. Present study describes a novel long-acting parenteral formulation of combination antiretroviral (cARV) loaded nano-drugs for treating chronic HIV-1 (cHIV) in a humanized-BLT (hu-BLT) mice model. The cARV (elvitegravir + tenofovir alafenamide + emtricitabine; EVG + TAF + FTC) drugs (mimicking marketed Genvoy® one-pill for HIV-treatment) were encapsulated in poly (lactic-co-glycolic acid) nanoparticles (NPs). To establish cHIV, hu-BLT mice were intravaginally challenged with HIV-1 and maintained for 15 weeks. Plasma viral load (pVL) was monitored …